Clesacostat
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Clesacostat
- DrugBank Accession Number
- DB18956
- Background
Clesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 502.571
Monoisotopic: 502.221620082 - Chemical Formula
- C28H30N4O5
- Synonyms
- 4-(6-methoxy-4-(7-oxo-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro(indazole-5,4'- piperidine)-1'-carbonyl)pyridin-2-yl)benzoic acid
- Benzoic acid, 4-(6-methoxy-4-((1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro(5h-indazole-5,4'-piperidin)-1'-yl)carbonyl)-2-pyridinyl)-
- External IDs
- PF-05221304
- PF05221304
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 752DF9PPPI
- CAS number
- 1370448-25-1
- InChI Key
- LXZMHBHEXAELHH-UHFFFAOYSA-N
- InChI
- InChI=1S/C28H30N4O5/c1-17(2)32-25-21(16-29-32)14-28(15-23(25)33)8-10-31(11-9-28)26(34)20-12-22(30-24(13-20)37-3)18-4-6-19(7-5-18)27(35)36/h4-7,12-13,16-17H,8-11,14-15H2,1-3H3,(H,35,36)
- IUPAC Name
- SMILES
- COC1=CC(=CC(=N1)C1=CC=C(C=C1)C(O)=O)C(=O)N1CCC2(CC1)CC1=C(N(N=C1)C(C)C)C(=O)C2
References
- General References
- Not Available
- External Links
- ChemSpider
- 114641970
- BindingDB
- 50511112
- ChEMBL
- CHEMBL4567446
- ZINC
- ZINC000114805174
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data2 Completed Basic Science Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD / Nonalcoholic Steatohepatitis With Liver Fibrosis 1 somestatus stop reason just information to hide 2 Completed Basic Science Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD / Steatohepatitis, Nonalcoholic 1 somestatus stop reason just information to hide 2 Completed Treatment Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD 1 somestatus stop reason just information to hide 2 Completed Treatment Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD / Steatohepatitis, Nonalcoholic 1 somestatus stop reason just information to hide 1 Completed Basic Science Healthy Normals 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 27, 2024 16:23 / Updated at June 28, 2024 04:46